Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel analog of TRH, YM14673, causes a decrease in brain TRH receptors in vitro

T Monden1, H Mizuma, M Yamada

  • 1First Department of Internal Medicine, Gunma University, School of Medicine, Maebashi, Japan.

Endocrine Research
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Neuropeptide Cyclo(His-Pro) Levels are Increased in Diabetic Ketoacidosis and Fall with Treatment in Parallel with Levels of Glucagon.

Nutritional neuroscience·2016
Same author

A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques.

Translational psychiatry·2014
Same author

Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART.

Journal of human hypertension·2011
Same author

Mental fatigue-induced decrease in levels of several plasma amino acids.

Journal of neural transmission (Vienna, Austria : 1996)·2006
Same author

Relationship between plasma cyclo (His-Pro), a neuropeptide common to processed protein-rich food, and C-peptide/insulin molar ratio in obese women.

Nutritional neuroscience·2002
Same author

Expression of thyrotropin receptors in rat thymus.

Life sciences·2001

Novel thyrotropin-releasing hormone (TRH) analog YM14673 modulates TRH receptors in rat brains. This neuropharmacological action occurs via interaction with TRH binding sites, particularly in the cerebral cortex.

Area of Science:

  • Neuropharmacology
  • Endocrinology
  • Biochemistry

Background:

  • The precise biochemical pathways underlying the neuropharmacological effects of thyrotropin-releasing hormone (TRH) analogs in the brain are not fully understood.
  • Investigating novel TRH analogs is crucial for elucidating brain TRH receptor interactions and their therapeutic potential.

Purpose of the Study:

  • To investigate the in vitro effects of YM14673, a novel TRH analog, on TRH receptors in rat brain tissue.
  • To determine the mechanism by which YM14673 exerts its neuropharmacological actions.

Main Methods:

  • In vitro binding assays using [3H]YM14673 and brain plasma membranes from rats.
  • Dose-dependent preincubation experiments with YM14673 and other compounds (DN1417, cyclo(His-Pro), methionine-enkephalin).

Related Experiment Videos

  • Analysis of TRH binding in various brain regions, including cerebral cortex, hypothalamus, striatum, midbrain, hippocampus, and pons-medulla.

    • Main Results:

    • YM14673 did not exhibit direct binding to rat brain TRH receptors.
    • Preincubation with YM14673 caused a dose-dependent reduction in TRH binding, independent of competition or metabolite formation.
    • This effect on TRH binding was specifically observed in cerebral cortical membranes and not in other tested brain regions.
    • Other TRH analogs and peptides did not replicate this effect.

    Conclusions:

    • YM14673 modulates TRH binding sites in the rat brain, particularly within the cerebral cortex.
    • The neuropharmacological effects of YM14673 are mediated through interaction with TRH binding sites, rather than direct receptor binding.
    • These findings provide insight into the mechanism of action for TRH analogs in the central nervous system.